What we do as NaturalAntibody is not only to optimize the drug development process, but also to enhance their therapeutic properties. I dealt with this scientifically for many years at the university, until the time came to confront scientific achievements with the needs of business - says Konrad Krawczyk, co-founder and CEO at NaturalAntibody.

Impact investing is still modestly represented in the structure of the Polish venture capital market. We are all the more pleased to announce a new company in the investment portfolio of WP2 Investments. Wellbee- welcome to the blue family of WP2 Investments!